UNISANTIS
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

UNISANTIS Trademark

Serial Number: 79133104 • Registration: 4676939

UNISANTIS is a trademark filed by Alpinia Institute for Life Sciences AG on May 1, 2013. The trademark is classified under Class 1 (Chemicals), Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 29 (Meats & Processed Foods), Class 30 (Staple Foods). The application is currently registered and active.

Owner Contact Info

Alpinia Institute for Life Sciences AG (9 trademarks)

Bahnhofstrasse 34

Entity Type: 98

Alpinia Laudanum Institute of Phytopharmaceutical Sciences AG (7 trademarks)

Bahnhofstrasse 34
CH-8880 Walenstadt , CH

Entity Type: 99

Trademark Details

Filing Date

May 1, 2013

Registration Date

January 27, 2015

Published for Opposition

November 11, 2014

Cancellation Date

May 1, 2023

Goods & Services

Coffee, tea, cocoa, sugar, rice, tapioca, sago, artificial coffee; flour and preparations made from cereals, namely, cereal-based snack foods, cereal bars, cereal capsules, cereal oil capsules, cereal powders, cereal granulates and cereal flakes; bread, fine bakery and pastry products, ice; honey, treacle; yeast, baking powder, salt, mustard, vinegar, sauces, spices, ice for refrigerating; plant-based cooked dishes and semi-cooked dishes consisting primarily of cooked or semi-cooked whole grains

Meat, fish, poultry and game, not live; meat extracts; preserved, dried and cooked fruits and vegetables; unflavoured and unsweetened gelatins; jellies, jams, fruit compote, eggs, cheeses, milk and dairy products excluding ice cream, ice milk and frozen yogurt; olive oil and other edible oils and fats; cooked dishes and semi-cooked dishes consisting primarily of meat, fish or poultry

Nutritional supplements for medical use; non-medical nutritional supplements of animal origin; non-medical cereal-based nutritional supplements; non-medical nutritional supplements based on fruits and vegetables; phytopharmaceutical medicines for the treatment of human and animal diseases, namely, cancer, neurological, inflammatory, cardiovascular, immunological, gastro-intestinal and infective diseases and diseases of the mucosa; active plant agents and plant extracts for medical use; medical, pharmaceutical, veterinary and sanitary products for the treatment of human and animal diseases, namely, cancer, neurological, inflammatory, cardiovascular, immunological, gastro-intestinal and infective diseases and diseases of the mucosa; dietetic substances for medical use, namely, herbs, fruits, spices, vegetables, algae, fungi or in the nature of minerals, trace-elements, vitamins, micro-nutrients, food for babies; adjuvants for medical use; amino acids for medical use; anesthetics for non-surgical use; analgesics; vermifuges; antibiotics; logs for pharmaceutical use; biological preparations for the treatment of human and animal diseases, namely, cancer, neurological, inflammatory, cardiovascular, immunological, gastro-intestinal and infective diseases and diseases of the mucosa; chemical preparations for medical use, namely, for the treatment of human and animal diseases, namely, cancer, neurological, inflammatory, cardiovascular, immunological, gastro-intestinal and infective diseases and diseases of the mucosa; chemical reagents for medical or veterinary use; chemico-pharmaceutical preparations for the treatment of human and animal diseases, namely, cancer, neurological, inflammatory, cardiovascular, immunological, gastro-intestinal and infective diseases and diseases of the mucosa; ferments for pharmaceutical use; hormones for medical use; medical infusions for the treatment of human and animal diseases, namely, cancer, neurological, inflammatory, cardiovascular, immunological, gastro-intestinal and infective diseases and diseases of the mucosa; medicines for dental use; medicines for the treatment of human and animal diseases, namely, cancer, neurological, inflammatory, cardiovascular, immunological, gastro-intestinal and infective diseases and diseases of the mucosa; radiological contrast substances for medical use; chemical reagents for medical or veterinary use; steroids, vitamins and vitamin preparations; medical preparations for slimming

Cosmetics; soaps; perfumery; essential oils; hair lotions and cosmetics; dentifrices; non-medicated products for dental care, namely, toothpaste, mouth wash, dental rinse, chewing gum for dental care and dental spray

Active plant agents and plant extracts in particular for research purposes

Pharmacy advice in the nature of pharmaceutical advice; preparation of pharmaceutical formulas for pharmaceutical use; preparation of plant extracts for pharmaceutical use

Scientific and technological services, namely, research and development services in the field of pharmaceuticals; research and development of new products for others; medical research; scientific research and industrial research in the field of pharmaceuticals; scientific and technological research and design services in the pharmaceutical and biotechnology fields; pharmaceutical industrial research and analysis services; services provided by a pharmaceutical laboratory; pharmaceutical research and development; scientific services, namely, development of medicines, active agents and vaccines; scientific services, namely, development of food supplements

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Nov 27, 2023 DENC
DEATH OF INTERNATIONAL REGISTRATION
Nov 27, 2023 DETH
REFUSAL PROCESSED BY IB
Jul 18, 2022 RFNT
NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Aug 28, 2021 DENC
DEATH OF INTERNATIONAL REGISTRATION
Aug 28, 2021 DETH
CANCELLED SECTION 71
Aug 13, 2021 C71T
CHANGE OF NAME/ADDRESS REC'D FROM IB
May 15, 2021 ADCH
FINAL DECISION TRANSACTION PROCESSED BY IB
Aug 28, 2015 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jun 1, 2015 FICS
FINAL DISPOSITION PROCESSED
Jun 1, 2015 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 27, 2015 FICR
REGISTERED-PRINCIPAL REGISTER
Jan 27, 2015 R.PR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jan 15, 2015 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Dec 31, 2014 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Dec 31, 2014 OPNR
NEW REPRESENTATIVE AT IB RECEIVED
Dec 18, 2014 NREP
PUBLISHED FOR OPPOSITION
Nov 11, 2014 PUBO
NOTIFICATION PROCESSED BY IB
Nov 8, 2014 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Oct 22, 2014 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Oct 22, 2014 OP2R
NOTICE OF PUBLICATION
Oct 22, 2014 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Oct 6, 2014 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 1, 2014 CNSA
EXAMINERS AMENDMENT MAILED
Sep 26, 2014 CNEA
EXAMINER'S AMENDMENT ENTERED
Sep 26, 2014 XAEC
EXAMINERS AMENDMENT -WRITTEN
Sep 26, 2014 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 18, 2014 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 18, 2014 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 18, 2014 TROA
REFUSAL PROCESSED BY IB
May 16, 2014 RFNT
NON-FINAL ACTION MAILED
Mar 18, 2014 CNRT
NON-FINAL ACTION WRITTEN
Mar 14, 2014 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 19, 2014 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 19, 2014 CRFA
ASSIGNED TO LIE
Feb 12, 2014 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 5, 2014 TROA
REFUSAL PROCESSED BY IB
Sep 7, 2013 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 21, 2013 RFCS
REFUSAL PROCESSED BY MPU
Aug 21, 2013 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 21, 2013 RFCR
NON-FINAL ACTION WRITTEN
Aug 20, 2013 CNRT
ASSIGNED TO EXAMINER
Aug 20, 2013 DOCK
APPLICATION FILING RECEIPT MAILED
Jul 30, 2013 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 26, 2013 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jul 25, 2013 REPR